Presented by: Karen Marzlin and Cynthia Webner
Save money! CNEA offers a 12 month subscription that includes ALL our online CE courses. Access to more than 240 CEs for one price. Click here to learn more.
This 3-day course includes sessions 4, 5, and 6 of the Institute of Cardiovascular Excellence and are included in the purchase of that 8-session program. These 3 sessions are offered as a standalone program and may be purchased here.
This 3 day program includes a full day on each of these topics: 1) All Things Coronary Artery Disease and Acute Coronary Syndromes, 2) Everything Heart Failure and Hypertension, and 3) Cardiac Pathophysiology Potpourri: Valvular, Inflammatory, Myopathies, Channelopathies & Obstructive Shock.
Upon completion of this course, the participant will be able to:
- Discuss the physiological basis for coronary artery disease and acute coronary syndromes.
- Review ECG findings specific to the recognition of ACS.
- Compare and contrast treatment strategies for STEMI from treatment strategies for NonST-ACS.
- Review antiplatelet strategies in the treatment of ACS.
- Identify complications in the post myocardial infarction patient.
- Differentiate heart failure with reduced LVEF from heart failure with preserved LVEF.
- Describe the NYHA classification system and the ACC/AHA stages of heart failure.
- Recognize heart failure patients through physical assessment and diagnostic results.
- Correlate pharmacological treatment strategies with current evidence-based guidelines.
- Identify non-pharmacological treatment strategies for heart failure with reduced and preserved LVEF.
- Identify hypertension treatment strategies based on the most recent evidence-based guidelines.
- Correlate the signs and symptoms of valvular heart disease with the associated hemodynamic changes.
- Discuss evidence-based treatment strategies for valvular heart disease.
- Identify pathophysiological changes associated with restrictive, hypertrophic, arrhythmogenic and Takotsubo cardiomyopathies.
- Identify clinical presentation associated with restrictive, hypertrophic, arrhythmogenic and Takotsubo cardiomyopathies.
- Discuss treatment options for the patient with restrictive, hypertrophic, arrhythmogenic and Takotsubo cardiomyopathies.
- Discusses etiology, presentation, and patient management strategies for pericarditis, endocarditis, and myocarditis.
- Correlate clinical assessment findings with obstructive shock states.
22.5 hours of continuing education (contact hours) are offered with this program, which includes 2.0 hour of pharmacology CE. CNEA is a provider approved by the California Board of Registered Nursing, provider number 15714.
For information on institutional pricing for this course contact firstname.lastname@example.org